Seasonal and pandemic influenza vaccines for the elderly and other risk groups: A review of available data

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 10, 2009, Pages 654-659

  Kramarz, Piotr ^a   Ciancio, Bruno ^a   Nicoll, Angus ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

Coverage; Influenza; Vaccination

Indexed keywords

INFLUENZA VACCINE;

AGED; HEALTH CARE PERSONNEL; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NURSING HOME PATIENT; PANDEMIC; REVIEW; SEASONAL VARIATION; VIRUS TRANSMISSION;

EID: 72249108978     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.797     Document Type: Review

References (55)

1. Nichol KL. Complications of influenza and benefits of vaccination. Vaccine. 1999; 17 (Suppl 1): S47-52.
2. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine. 1999; 17 Suppl 1: S3-10.
3. Fleming DM, Elliot AJ. The impact of influenza on the health and health care utilisation of elderly people. Vaccine. 2005; 23 Suppl 1: S1-9.
4. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003; 362: 1733-1745.
5. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289: 179-186. (Pubitemid 36068705)
6. Mereckiene J, Cotter S, Nicoll A, et al. National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill. 2008; 13.
7. Prevention and control of influenza pandemics and annual epidemics. Fifty-sixth World Health Assembly; Resolution WHA56. Available at: http://www.evm-vaccines.org/pdfs/wha-resolution-ipd.pdf.
8. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect. 2009; 58: 446-458.
9. Kroneman MW, van Essen GA. Stagnating influenza vaccine coverage rates among high-risk groups in Poland and Sweden in 2003/4 and 2004/5. Euro Surveill. 2007; 12: E1-2.
10. Blank PR, Freiburghaus AU, Ruf BR, et al. Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07. Med Klin (Munich). 2008; 103: 761-768.
11. Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine. 2005; 23: 2251-2255. (Pubitemid 40341461)
12. Maltezou HC. Nosocomial influenza: need to vaccinate health-care workers. Vaccine. 2009; 27: 177-178.
13. Maltezou HC, Drancourt M. Nosocomial influenza in children. J Hosp Infect. 2003; 55: 83-91.
14. Dash GP, Fauerbach L, Pfeiffer J, et al. APIC position paper: Improving health care worker influenza immunization rates. Am J Infect Control. 2004; 32: 123-125. (Pubitemid 38620831)
15. LaForce FM, Nichol KL, Cox NJ. Influenza: virology, epidemiology, disease, and prevention. Am J Prev Med. 1994; 10 Suppl: 31-44. (Pubitemid 24325975)
16. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis. 2002; 2: 145-155.
17. Stott DJ, Kerr G, Carman WF. Nosocomial transmission of influenza. Occup Med (Lond). 2002; 52: 249-253.
18. Hansen S, Stamm-Balderjahn S, Zuschneid I, et al. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect 2007; 65: 348-353. (Pubitemid 46477978)
19. Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999; 281: 908-913. (Pubitemid 29124634)
20. van der Wouden, JC, Bueving HJ, Poole P. Preventing influenza: an overview of systematic reviews. Respir Med. 2005; 99: 1341-1349. (Pubitemid 41487492)
21. Burls A, Jordan R, Barton P, et al. Vaccinating healthcare workers against influenza to protect the vulnerable - is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine. 2006; 24: 4212-4221. (Pubitemid 44308224)
22. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006; 333: 1241.
23. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997; 175: 1-6. (Pubitemid 27020817)
24. Lemaitre M, Meret T, Rothan-Tondeur M, et al. Effect of Influenza Vaccination of Nursing Home Staff on Mortality of Residents: A Cluster-Randomized Trial. J Am Geriatr Soc. 2009 Aug 4. [Epub ahead of print].
25. Harper SA, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005; 53: 1-40.
26. Looijmans-van den Akker I, van Delden JJ, Verheij TJ, et al. Which determinants should be targeted to increase influenza vaccination uptake among health care workers in nursing homes? Vaccine. 2009; 27: 4724-4730.
27. Helcl J, Cástková J, Benes C, et al. Control of occupational hepatitis B among healthcare workers in the Czech Republic, 1982 to 1995. Infect Control Hosp Epidemiol. 2000; 21: 343-346.
28. Sprenger MJ, Mulder PG, Beyer WE, et al. Impact of influenza on mortality in relation to age and underlying disease, 1967-1989. Int J Epidemiol. 1993; 22: 334-340.
29. Nichol KL, Grimm MB, Peterson DC. Immunizations in long-term care facilities: policies and practice. J Am Geriatr Soc. 1996; 44: 349-355. (Pubitemid 26115544)
30. Simor AE. Influenza outbreaks in long-term-care facilities: how can we do better? Infect Control Hosp Epidemiol. 2002; 23: 564-567.
31. Gupta A, Morris G, Thomas P, Hasan M. Influenza vaccination coverage in old people's home in Carmarthenshire, UK, during the winter of 1998/99. Vaccine. 2000; 18: 2471-2475.
32. Influenza vaccines. Wkly Epidemiol Rec. 2005; 80: 279-287.
33. Govaert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994; 272: 1661-1665.
34. Rivetti D, Jefferson T, Thomas R, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2006; 3: CD004876.
35. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995; 123: 518-527.
36. Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007; 7: 658-666. (Pubitemid 47444564)
37. Baker CJ, Schaffner W, Zimmerman RK. Importance of influenza vaccination for children. Am Fam Physician. 2007; 76: 343-344; author reply 344, 347.
38. Hak E, Verheij TJ, Grobbee DE, et al. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health. 2002; 56: 951-955. (Pubitemid 35440661)
39. Groenwold RH, Hoes AW, Hak E. Impact of influenza vaccination on mortality risk among the elderly. Eur Respir J. 2009; 34: 56-62.
40. Auewarakul P, Kositanont U, Somsathapomkul P, et al. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine. 2007; 25: 659-663. (Pubitemid 44856109)
41. Chiu SS, Peiris JS, Chan KH, et al. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics. 2007; 119: 1076-1082.
42. Kenney RT, Frech SA, Muenz LR, et al. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med. 2004; 351: 2295-2301. (Pubitemid 39552745)
43. Glenn GM, Kenney RT, Ellingsworth LR, et al. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev Vaccines. 2003; 2: 253-267.
44. Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004; 351: 2286-2294. (Pubitemid 39552744)
45. Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis. 2008; 198: 650-658.
46. CDC. Swine Influenza A (H1N1) Infection in Two Children - Southern California, March-April 2009. MMWR. 2009; 58: 400-402.
47. Update: novel influenza A (H1N1) virus infection - Mexico, March-May, 2009. MMWR Morb Mortal Wkly Rep. 2009; 58: 585-589.
48. New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009. Wkly Epidemiol Rec. 2009; 84: 261-264.
49. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009; 360: 2605-2615.
50. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. MMWR Morb Mortal Wkly Rep. 2009; 58: 826-829.
51. ECDC. ECDC Interim Risk Assessment Pandemic (H1N1) 2009 influenza. ECDC Web Portal. 2009. Available at http://ecdc.europa.eu/en/health-topics/Documents/ 0908-Influenza-AH1N1-Risk-Assessment.pdf.
52. Fiore AC. Novel influenza A (H1N1) Epidemiology Update. Advisory Committee on Immunization Practices Meeting July 2009. 2009. Available at http://www.cdc.gov/vaccines/recs/ACIP/downloads/mtg-slides-jul09-flu/ 02-Flu-Fiore.pdf.
53. CDC. Use of Influenza A (H1N1) 2009 Monovalent Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR. 2009; 58 (Early Release): 1-8.
54. CDC. Serum Cross-Reactive Antibody Response to a Novel Influenza A (H1N1) Virus After Vaccination with Seasonal Influenza Vaccine. MMWR. 2009; 58: 521-524.
55. ECDC. ECDC Interim Guidance. Use of specific pandemic influenza vaccines during the H1N1 2009 pandemic, August 2009. ECDC Web Portal. 2009. Available at http://ecdc.europa.eu/en/publications/Publications/0908-GUI-Pandemic-Influenza- Vaccines-during-the-H1N1-2009-Pandemic.pdf.